Long-term benefit of one thrombolytic over another

R. Roberts

doi:10.1161/01.CIR.94.6.1203

Back

Journal article

Long-term benefit of one thrombolytic over another

R. Roberts

Circulation, Vol.94(6)

1996

DOI: https://doi.org/10.1161/01.CIR.94.6.1203

Abstract

Editorials

myocardial infarction

prognosis

thrombolysis

thrombosis

streptokinase

tissue plasminogen activator

fibrinolytic agent

heparin

acute heart infarction

blood clot lysis

bypass surgery

cost benefit analysis

editorial

follow up

food and drug administration

morbidity

mortality

priority journal

clinical trial

comparative study

controlled clinical trial

drug combination

heart infarction

human

note

randomized controlled trial

treatment outcome

Drug Therapy, Combination

Fibrinolytic Agents

Humans

Randomized Controlled Trials

Metrics

1 Record Views

Details

Title: Long-term benefit of one thrombolytic over another
Creators: R. Roberts - Bugher Foundation
Publication Details: Circulation, Vol.94(6)
Identifiers: 00097322; 991006029257102656
Academic Unit: Cardiology
Language: English
Resource Type: Journal article

Long-term benefit of one thrombolytic over another

Abstract

Related links

Metrics

Details